IRIS PubliCatt

Grieco, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.883
NA - Nord America 6.189
AS - Asia 2.252
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 25
SA - Sud America 19
Totale 15.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.143
DE - Germania 2.856
SE - Svezia 1.307
CN - Cina 1.017
UA - Ucraina 692
IT - Italia 621
SG - Singapore 590
IE - Irlanda 367
GB - Regno Unito 237
ID - Indonesia 229
FR - Francia 223
FI - Finlandia 193
RU - Federazione Russa 172
TR - Turchia 161
IN - India 141
PL - Polonia 62
BE - Belgio 41
CA - Canada 31
HK - Hong Kong 29
IR - Iran 26
AU - Australia 25
JP - Giappone 24
EU - Europa 22
NL - Olanda 15
RO - Romania 15
CH - Svizzera 12
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
PT - Portogallo 10
BR - Brasile 9
IL - Israele 8
ES - Italia 7
HU - Ungheria 7
DK - Danimarca 6
AT - Austria 5
BZ - Belize 5
LT - Lituania 5
MK - Macedonia 5
MX - Messico 5
PE - Perù 5
CL - Cile 4
EE - Estonia 4
EG - Egitto 4
KR - Corea 4
NZ - Nuova Zelanda 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GR - Grecia 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
NO - Norvegia 2
PR - Porto Rico 2
SC - Seychelles 2
SD - Sudan 2
A1 - Anonimo 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DJ - Gibuti 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
Totale 15.423
Salva come PNG Salva come JPEG
Città #
Chandler 1.337
Singapore 468
Ashburn 448
Jacksonville 405
Dublin 365
San Mateo 332
Nanjing 232
Jakarta 226
Ann Arbor 223
Wilmington 194
Nürnberg 180
Boston 176
Cattolica 151
Izmir 151
Houston 149
New York 148
Dearborn 139
Princeton 122
Woodbridge 119
Munich 115
Moscow 109
Beijing 103
Marseille 98
Nanchang 98
Milan 90
Rome 88
Boardman 73
Seattle 70
Redwood City 67
Lawrence 66
Redmond 63
Chicago 60
Fairfield 57
Hebei 55
Kraków 55
Helsinki 53
Tianjin 52
Mountain View 46
Bremen 45
Shenyang 43
Kunming 42
Brussels 41
Los Angeles 41
University Park 39
Jiaxing 36
Norwalk 36
Zhengzhou 36
Changsha 35
Hangzhou 31
San Jose 30
Augusta 28
Fremont 28
Jinan 26
Hong Kong 25
Washington 24
Cambridge 22
Guangzhou 22
Andover 20
Falls Church 20
Pune 20
Simi Valley 20
London 18
Lancaster 17
Saint Petersburg 17
Leawood 15
Ningbo 15
Lanzhou 14
Santa Clara 14
San Diego 13
Taizhou 13
Detroit 12
Toronto 12
Abidjan 10
Frankfurt am Main 10
Indiana 10
Kish 10
San Francisco 10
Brno 9
Changchun 9
Buffalo 8
Campagna 8
Edinburgh 8
Ottawa 8
Paris 8
Shanghai 8
Amsterdam 7
Atlanta 7
Busto Arsizio 7
Hefei 7
Monmouth Junction 7
Phoenix 7
Provo 7
Tappahannock 7
Warsaw 7
Zurich 7
Chengdu 6
Falkenstein 6
Las Vegas 6
Portland 6
Stockholm 6
Totale 8.069
Salva come PNG Salva come JPEG
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 273
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 256
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 211
A phase II study of sunitinib in advanced hepatocellular carcinoma 206
13C-methionine breath tests for mitochondrial liver function assessment. 203
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 181
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 181
-Hepatic steatosis and vascular disease 170
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 160
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 157
134C-breath tests in the study of mitochondrial liver function 153
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 152
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 149
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 147
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 145
Effect of sildenafil on diabetic gastropathy. 141
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 139
13C-breath tests in the study of microsomial liver function 139
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 128
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 126
recurrent acute hepatitis associated with use of cetrizine 126
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 126
13C-methionine breath tests for mitochondrial liver function assessment 124
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 122
Potential use of liver function breath tests in the clinical practice. 120
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 119
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 117
Vanishing-recurrent benign liver lesions 115
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 113
13C-breath tests in the study of mitochondrial liver function 112
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 112
Faecal calprotectin concentrations in untreated coeliac patients 108
[The treatment of hepatocellular carcinoma: an update] 106
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 105
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 105
gastroesophageal reflux disease: facts and uncertaines 104
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 104
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 102
-Fatty liver and drugs 102
Tromboembolism and breast cancer: the hidden risk for patient and physician 102
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 102
Cryoglobulinemia: a true internistic disease? 101
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 100
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 100
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 99
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 99
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 99
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 99
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 99
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 96
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 96
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 93
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 92
Liver transplantation in patients with alcoholic liver disease: A retrospective study 92
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 91
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 89
Severe giant cell arteritis associated with essential thrombocythaemia. 87
-Nonalcoholic fatty liver disease: defining a common problem 87
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 86
Alcoholic and nonalcoholic forms of fatty liver disease. 86
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 86
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 86
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 86
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 86
Advanced colon cancer: staging and prognosis by CEA test 83
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 83
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target 83
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 81
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 80
Braised liver with herbs: the risks of naturopathic hepatoprotection. 80
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 79
Gender affects 13C-ketoisocaproic acid breath test 79
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 79
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 78
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 78
A giant calcified hepatic mass 77
Is coeliac disease a confounding factor in the diagnosis of NASH? 76
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 76
Drug-induced hepatitis 76
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 76
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 76
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 75
Review article: breath testing for human liver function assessment. 75
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 75
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 74
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 72
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 72
Impairment of recent thymic emigrants in HCV infection. 71
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 70
Acute fatty liver after malaria prophylaxis with mefloquine 69
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 69
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 68
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 68
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 68
anticholinergic syndrome due to " Devil's herb': when risks come from the ancient time 67
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 67
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 67
Totale 10.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.291 0 0 0 0 129 165 231 108 117 173 178 190
2020/20211.518 89 166 77 172 190 63 159 32 194 71 273 32
2021/20221.743 69 162 46 176 122 43 29 285 62 87 318 344
2022/20233.650 484 483 282 537 267 439 157 334 422 46 145 54
2023/20241.800 119 536 70 83 72 260 114 64 23 71 158 230
2024/2025919 99 108 322 116 274 0 0 0 0 0 0 0
Totale 15.635